dronabinol has been researched along with Drug Refractory Epilepsy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, KE; Galinkin, J; Helmkamp, LJ; Jost, K; Knupp, KG; Rice, JD; Sempio, C | 1 |
| Cock, H; Cross, JH | 1 |
| Chang-Douglass, S; Mulvihill, C; Pilling, S | 1 |
| Cáceres Guido, P; Caraballo, RH; Cruz, CV; García Bournissen, F; Pérez Montilla, CA; Reyes Valenzuela, G; Schaiquevich, PS | 1 |
| Bitton, J; Bourgeois-Tardif, S; Champagne, PO; Diaz, PL; Hebert, FO; Lewis, E; Major, P; Nowicki, M; Sanon, NT; Sell, E; Weil, AG | 1 |
| Devinsky, O; Gloss, D; O'Connell, BK | 1 |
| Goldstein, B; Saneto, R; Sulak, D | 1 |
2 review(s) available for dronabinol and Drug Refractory Epilepsy
| Article | Year |
|---|---|
A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Culture; Dronabinol; Drug Resistant Epilepsy; Evidence-Based Medicine; Humans; Lennox Gastaut Syndrome | 2020 |
Cannabinoids in treatment-resistant epilepsy: A review.
Topics: Adult; Anticonvulsants; Cannabidiol; Cannabinoids; Child; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Young Adult | 2017 |
5 other study(ies) available for dronabinol and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Prospective evaluation of oral cannabis extracts in children with epilepsy.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Cannabidiol; Cannabis; Child; Child, Preschool; Dronabinol; Drug Resistant Epilepsy; Female; Humans; Male; Medical Marijuana; Plant Extracts; Prospective Studies | 2019 |
Cannabis-based medicinal products: summary of NICE guidance.
Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Decision Making, Shared; Dronabinol; Drug and Narcotic Control; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Needs Assessment; Physicians, Primary Care; Practice Guidelines as Topic; Specialization; United Kingdom; Vomiting | 2020 |
An Ultrafast Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for Cannabidiol Monitoring in Pediatric Refractory Epilepsy.
Topics: Cannabidiol; Child; Chromatography, High Pressure Liquid; Dronabinol; Drug Resistant Epilepsy; Humans; Limit of Detection; Tandem Mass Spectrometry | 2021 |
Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series.
Topics: Cannabidiol; Cannabis; Child; Dronabinol; Drug Resistant Epilepsy; Humans; Plant Extracts; Seizures | 2022 |
The current status of artisanal cannabis for the treatment of epilepsy in the United States.
Topics: Adolescent; California; Cannabinoids; Cannabis; Child; Child, Preschool; Dronabinol; Drug Resistant Epilepsy; Female; Humans; Infant; Male; Medical Marijuana; Retrospective Studies; Treatment Outcome; United States; Washington | 2017 |